Pharmacologic control of uterine contractility. In vitro human and in vivo monkey studies.
Am J Obstet Gynecol, 1975/10/15;123(4):364-75.
Johnson WL, Harbert GM, Martin CB
PMID: 241259
Impact factor: 10.693
Abstract
The exact cause and mechanism of the onset of labor are unknown but the theories are many. There is considerable evidence that prostaglandins are potent stimulants of uterine activity and may play a role in the onset of labor. Prostaglandin release may be the natural mediator of uterine contractions during labor. A group of anti-inflammatory compounds (aspirin-like compounds) that inhibit prostaglandin synthesis include indomethacin and fenoprofen. Inhibition of prostaglandin production is a reasonable approach to inhibiting premature labor. An excised muscle strip technique was used as a screening procedure for pharmacologic depression of human uterine activity in vitro, testing isoxsuprine, mesuprine, Alupent, ritodrine, indomethacin, and fenoprofen. The prostaglandin antagonists indomethacin and fenoprofen exhibited marked depressant activity. These drugs were further tested in an in vivo rhesus monkey preparation measuring uterine activity, maternal blood pressure, uterine blood flow, fetal heart rate, fetal blood pressure, and blood gases. Fenoprofen is effective in reducing uterine contractility without serious maternal or fetal side effects and shows promise as a clinically effective agent for pharmacologic control of premature labor.
MeSH terms
Adrenergic beta-Agonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Fenoprofen; Fetus; Haplorhini; Humans; In Vitro Techniques; Indomethacin; Isoxsuprine; Macaca mulatta; Metaproterenol; Myometrium; Phenethylamines; Pregnancy; Ritodrine; Sulfonamides; Uterine Contraction
More resources
EndNote: Download